Amgen invests additional $300M in Puerto Rico drug factory
Amgen is investing an additional $300 million into its drug manufacturing facility in Juncos, Puerto Rico. This follows a $650 million commitment made last year to the same site. The facility supplies medicines to over 60 countries. The investment underscores Amgen's expansion of biologics production capacity in Puerto Rico.
Key facts
- Amgen is investing an additional $300 million into its Juncos facility in Puerto Rico.
- The investment builds on $650 million committed last year.
- The facility supplies medicines to more than 60 countries.
- The investment is for biologics manufacturing.
Entities
Institutions
- Amgen
Locations
- Juncos
- Puerto Rico
Sources
- Quartz —